2.3.3Other Remuneration Information

This section provides further information to increase transparency and accountability for the execution of RP 2022 and aims to allow shareholders, potential investors and other stakeholders to better assess Management Board remuneration.

The following table includes further details regarding the various (historical) share plans, including the changes throughout 2025.


Conditions of and information regarding share plans

The main conditions of share award plans

Information regarding the reported financial year

Opening balance1

During the year

Closing balance2

Plan specification

Grant and vesting dates

End of retention period

Shares held at the beginning of the year

Shares granted (# / EUR x 1,000)3

Shares vested (# / EUR x 1,000)4

Shares subject to a retention period

Øivind Tangen,
CEO

Ownership
Shares 2022

01-01-2022

01-01-2025

1,572

0 / 0

0 / 0

Value Creation
Stake 20225

06-04-2022

06-04-2027

32,073

0 / 0

0 / 0

32,073

Value Creation
Stake 2023

01-01-2023

01-01-2028

43,312

0 / 0

0 / 0

43,312

Value Creation
Stake 2024

01-01-2024

01-01-2029

45,628

0 / 0

0 / 0

45,628

Additional Value
Creation Stake
20246

12-04-2024

12-04-2029

16,502

0 / 0

0 / 0

16,502

Value Creation
Stake 2025

01-01-2025

01-01-2030

96,437 / 1,658

96,437 / 1,658

67,269

Douglas Wood,
CFO

Value Creation
Stake 2020

01-01-2020

01-01-2025

35,554

0 / 0

0 / 0

Value Creation
Stake 2021

01-01-2021

01-01-2026

34,212

0 / 0

0 / 0

34,212

Value Creation
Stake 2022

01-01-2022

01-01-2027

34,389

0 / 0

0 / 0

34,389

Additional Value Creation Stake
20226

06-04-2022

06-04-2027

1,304

0 / 0

0 / 0

1,304

Value Creation
Stake 2023

01-01-2023

01-01-2028

36,177

0 / 0

0 / 0

36,177

Value Creation
Stake 2024

01-01-2024

01-01-2029

38,129

0 / 0

0 / 0

38,129

Additional Value Creation Stake
20246

12-04-2024

12-04-2029

2,859

0 / 0

0 / 0

2,859

Value Creation
Stake 2025

01-01-2025

01-01-2030

74,661 / 1,283

74,661 / 1,283

41,421

  • 1 Opening balance consists of shares held and vested grants for conditional plans at assumed maximum target.
  • 2 Closing balance consists of the full grant and vesting of the relevant plan, including any sell-to-cover performed to compensate a wage tax impact.
  • 3 Converted at the share price at the date of grant.
  • 4 Converted at the share price at the date of vesting.
  • 5 Pro-rata VCS following appointment to Management Board per April 6, 2022.
  • 6 Additional Value Creation Stake granted due to salary increase.

In the table below, information on the annual change of remuneration of each individual Management Board member is set out over the five most recent financial years. In addition, the performance of the Company (measured in Directional Underlying EBITDA and TRIFR) is displayed as well as the average remuneration on a full-time equivalent basis of employees of the Company.


Comparative table on the change of remuneration and Company performance over the last five reported financial years

in thousands of EUR, except Company's performance

Annual Change1

2021

2022

2023

2024

2025

Øivind Tangen, CEO2

-

1,975

10% / 2,175

40% / 3,039

29%/3,914

Douglas Wood, CFO

2,182

(15%) / 1,906

14% / 2,167

5% / 2,273

26%/2,694

Company's performance

Underlying Directional EBITDA
in million US$

931

8% / 1,010

6% / 1,0753

20% / 1,2944

30% /1,6815

TRIFR6

0.06

50% / 0.12

(50%) / 0.08

25% / 0.10

620%/0.72

Average employee expenses on a full-time equivalent basis

Average employee expenses of the Company7

102

8% / 111

2% / 113

8% / 122

(4%) /117

  • 1 Annual change in percentage is calculated comparative to the amount of the current year.
  • 2 CEO and Management Board member from April 12, 2024, before that date COO and Management Board member from April 6, 2022.
  • 3 Underlying EBITDA reflects the following adjustments: i. impact of the sale of Liza Destiny earlier than planned; ii. implementation costs of an optimization plan related to the Company's support functions; and iii. impact of the delay in commencement of a charter by a client notwithstanding the on-target delivery of the vessel by the Company.
  • 4 Underlying EBITDA restated for: DNY/PTY sale in 2024.
  • 5 Underlying EBITDA reflects the following adjustment: Thunderhawk profit on sale of USD 28mln removed from the reported Directional EBITDA.
  • 6 Total recordable injury frequency rate trends are positive when downwards.
  • 7 The average employee expenses of the company are based on the IFRS expenses including share based payments. The average employee expenses are influenced by both the composition of the population both in function as well as geographical location and the related foreign currency impacts. This calculation has a different basis than the pay-ratio calculation in accordance with the Dutch corporate governance code.